SARS-CoV-2-specific circulating T follicular helper cells correlate with neutralizing antibodies and increase during early convalescence
暂无分享,去创建一个
B. Hahn | F. Bibollet-Ruche | P. Goepfert | A. Bansal | N. Erdmann | K. Qin | Ronnie M. Russell | R. Stoltz | Sushma Boppana | Jacob K. Files
[1] M. Davenport,et al. Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19 , 2021, Nature communications.
[2] M. Nussenzweig,et al. Evolution of antibody immunity to SARS-CoV-2 , 2021, Nature.
[3] Bjoern Peters,et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection , 2021, Science.
[4] P. Dormitzer,et al. COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses , 2020, Nature.
[5] J. Greenbaum,et al. Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity , 2020, Cell.
[6] V. Shinde,et al. Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine , 2020, The New England journal of medicine.
[7] E. Callaway. The coronavirus is mutating — does it matter? , 2020, Nature.
[8] T. Jin,et al. Peripheral CD4+ T cell subsets and antibody response in COVID-19 convalescent individuals. , 2020, The Journal of clinical investigation.
[9] P. Doherty,et al. Suboptimal SARS-CoV-2−specific CD8+ T cell response associated with the prominent HLA-A*02:01 phenotype , 2020, Proceedings of the National Academy of Sciences.
[10] L. Carter,et al. Functional SARS-CoV-2-specific immune memory persists after mild COVID-19 , 2020, medRxiv.
[11] E. Walsh,et al. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults , 2020, Nature.
[12] O. Kutsch,et al. Sustained Cellular Immune Dysregulation in Individuals Recovering from SARS-CoV-2 Infection , 2020, medRxiv.
[13] U. Reimer,et al. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19 , 2020, Nature.
[14] Nguyen H. Tran,et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial , 2020, The Lancet.
[15] Kelsey K. Finn,et al. The Loss of Bcl-6 Expressing T Follicular Helper Cells and the Absence of Germinal Centers in COVID-19. , 2020, SSRN.
[16] Sasikanth Manne,et al. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications , 2020, Science.
[17] Martin Linster,et al. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls , 2020, Nature.
[18] J. Mascola,et al. An mRNA Vaccine against SARS-CoV-2 — Preliminary Report , 2020, The New England journal of medicine.
[19] Nichollas E. Scott,et al. Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19 , 2020, Nature Medicine.
[20] C. Agrati,et al. Immunological and inflammatory profiles in mild and severe cases of COVID-19 , 2020, Nature Communications.
[21] A. Sette,et al. Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome , 2020, Science Immunology.
[22] C. Rice,et al. Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses , 2020, bioRxiv.
[23] W. Greene,et al. SARS-CoV-2-specific T cells exhibit phenotypic features reflecting robust helper function, lack of terminal differentiation, and high proliferative potential , 2020, bioRxiv.
[24] G. Wei,et al. Mutations Strengthened SARS-CoV-2 Infectivity , 2020, Journal of Molecular Biology.
[25] L. Du,et al. The Potency of an Anti-MERS Coronavirus Subunit Vaccine Depends on a Unique Combinatorial Adjuvant Formulation , 2020, Vaccines.
[26] J. Greenbaum,et al. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals , 2020, Cell.
[27] R. Baric,et al. DNA vaccine protection against SARS-CoV-2 in rhesus macaques , 2020, Science.
[28] P. Sorger,et al. SARS-CoV-2 infection protects against rechallenge in rhesus macaques , 2020, Science.
[29] Jianpeng Xiao,et al. Prolonged Persistence of SARS-CoV-2 RNA in Body Fluids , 2020, Emerging infectious diseases.
[30] M. Wener,et al. Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho , 2020, Journal of Clinical Microbiology.
[31] Xinquan Wang,et al. Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals , 2020, Immunity.
[32] Jianjun Liu,et al. Coronavirus Disease 2019 Test Results After Clinical Recovery and Hospital Discharge Among Patients in China , 2020, JAMA network open.
[33] M. Girardis,et al. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia , 2020, Nature Communications.
[34] Yong-tang Zheng,et al. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients , 2020, Cellular & Molecular Immunology.
[35] B. Cowie,et al. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19 , 2020, Nature Medicine.
[36] K. Yuen,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.
[37] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[38] G. Gao,et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.
[39] A. Westfall,et al. Peripheral CD4 T follicular cells induced by a conjugated pneumococcal vaccine correlate with enhanced opsonophagocytic antibody responses in younger individuals. , 2020, Vaccine.
[40] E. Wherry,et al. T follicular helper cells in human efferent lymph retain lymphoid characteristics. , 2019, The Journal of clinical investigation.
[41] Paul A. Harris,et al. The REDCap consortium: Building an international community of software platform partners , 2019, J. Biomed. Informatics.
[42] R. Koup,et al. Altered immune cell follicular dynamics in HIV infection following influenza vaccination , 2018, The Journal of clinical investigation.
[43] S. Kalayanarooj,et al. Activation of Peripheral T Follicular Helper Cells During Acute Dengue Virus Infection , 2018, The Journal of infectious diseases.
[44] D. Kaufmann,et al. Comparative analysis of activation induced marker (AIM) assays for sensitive identification of antigen-specific CD4 T cells , 2017, PloS one.
[45] A. Aderem,et al. Vaccination establishes clonal relatives of germinal center T cells in the blood of humans , 2017, The Journal of experimental medicine.
[46] Alessandro Sette,et al. A Cytokine-Independent Approach To Identify Antigen-Specific Human Germinal Center T Follicular Helper Cells and Rare Antigen-Specific CD4+ T Cells in Blood , 2016, The Journal of Immunology.
[47] M. Carrington,et al. HIV-1 Antibody Neutralization Breadth Is Associated with Enhanced HIV-Specific CD4+ T Cell Responses , 2015, Journal of Virology.
[48] K. Überla,et al. Enhancing the Quality of Antibodies to HIV-1 Envelope by GagPol-Specific Th Cells , 2015, The Journal of Immunology.
[49] H. Streeck,et al. Emerging concepts on T follicular helper cell dynamics in HIV infection. , 2014, Trends in immunology.
[50] Alessandro Sette,et al. Human circulating PD-1+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses. , 2013, Immunity.
[51] C. Mackay,et al. Circulating precursor CCR7(lo)PD-1(hi) CXCR5⁺ CD4⁺ T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure. , 2013, Immunity.
[52] Virginia Pascual,et al. Induction of ICOS+CXCR3+CXCR5+ TH Cells Correlates with Antibody Responses to Influenza Vaccination , 2013, Science Translational Medicine.
[53] K. Legge,et al. Pulmonary Infection with Influenza A Virus Induces Site-Specific Germinal Center and T Follicular Helper Cell Responses , 2012, PloS one.
[54] C. Mackay,et al. CXCR5 Expressing Human Central Memory CD4 T Cells and Their Relevance for Humoral Immune Responses , 2011, The Journal of Immunology.
[55] M. Altfeld,et al. Characteristics of the Earliest Cross-Neutralizing Antibody Response to HIV-1 , 2011, PLoS pathogens.
[56] T. Strutt,et al. Regulation of CD4+ T‐cell contraction during pathogen challenge , 2010, Immunological reviews.
[57] Christopher D. Paddock,et al. Cellular Immune Responses to Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection in Senescent BALB/c Mice: CD4+ T Cells Are Important in Control of SARS-CoV Infection , 2009, Journal of Virology.
[58] Zoe Moodie,et al. Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination. , 2007, Journal of immunological methods.
[59] M. Altfeld,et al. Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses. , 2003, Journal of immunological methods.
[60] W. Mcclements,et al. A simple and efficient method for the monitoring of antigen-specific T cell responses using peptide pool arrays in a modified ELISpot assay. , 2001, Journal of immunological methods.